NOVEL APPROACHES TO CRYOPRESERVATION OF HUMAN PANCREATIC ISLETS1
- 1 September 2001
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 72 (6) , 1005-1011
- https://doi.org/10.1097/00007890-200109270-00005
Abstract
Optimized conditions for survival and function of human islets must be defined if sufficient islets are to be recovered from a single human donor pancreas to reverse type-1 diabetes after isolation, cryopreservation, and transplantation. The objective of this study was to compare the cryoprotective effect of ethylene glycol (EG) with the standard cryoprotectant, dimethyl sulfoxide (DMSO), on isolated human islet survival and function. Furthermore, the effect of different addition protocols and equilibrium concentrations of the cryoprotectants were studied. Islets were isolated from human pancreata by using standard techniques of collagenase digestion and discontinuous Ficoll gradient purification. Aliquots of freshly isolated human islets were cryopreserved in six groups by using DMSO or EG. Cryoprotectants were added stepwise to produce a final concentration of 1.5 or 2.0 M, or added in a single step to a concentration of 1.5 M. Islets were cryopreserved by using established protocols and cultured for 48 hr at 37°C before assessment of percentage of recovery and in vitro viability. After cryopreservation, percentage of recovery of islets was significantly higher in the group treated with 1.5 M of DMSO added in a stepwise protocol (74±3%, mean±SEM) compared with the standard 2.0 M of DMSO (62±4%) (P <0.05, unpaired t test, n=6). There was no difference between the recovery of islets cryopreserved with either 1.5 M of DMSO stepwise (74±3%) or 1.5 M of DMSO one-step (69±3%). Islet recovery was higher in groups treated with DMSO compared with EG, regardless of concentration of cryoprotectant or addition protocol, although the difference was significant only when comparing DMSO and EG 1.5 M one-step. Furthermore, islets treated with 1.5 M of DMSO, added either stepwise (6.0±0.4) or in one-step (6.5±0.8), had significantly higher stimulation indices compared with islets treated with the standard cryoprotectant for human islets, 2.0 M of DMSO (4.5±0.5) (P <0.05). These results demonstrate that a lower concentration of DMSO (1.5 M) allows for the cryopreservation of human islets with superior survival and preservation of function post-culture compared with 2.0 M of DMSO and various concentrations of EG.Keywords
This publication has 21 references indexed in Scilit:
- Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive RegimenNew England Journal of Medicine, 2000
- Effect of Cryopreservation on the Survival and Function of Murine Islet Isografts and AllograftsCell Transplantation, 1998
- CRYOPRESERVATION OF RAT PANCREATIC ISLETSTransplantation, 1997
- Long-Term Metabolic Control by Rat Islet Grafts Depends on the Composition of the ImplantDiabetes, 1996
- Cryopreservation of Isolated Rat Islets of Langerhans in the Presence of Ethylene Glycol or Dimethyl Sulfoxide: Evaluation of Toxicity and the Dynamic Pattern of Subsequent Insulin Releasein VitroCryobiology, 1996
- Bulk Cryopreservation of Isolated Islets of LangerhansCell Transplantation, 1996
- THE EFFECT OF CRYOPRESERVATION ON THE SURVIVAL AND MHC ANTIGEN EXPRESSION OF MURINE ISLET ALLOGRAFTSTransplantation, 1993
- INHIBITION BY CYCLOSPORINE OF INSULIN SECRETION—A BETA CELL-SPECIFIC ALTERATION OF ISLET TISSUE FUNCTIONTransplantation, 1991
- Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in Type 1 (insulin-dependent) diabetes mellitusDiabetologia, 1991
- ISOLATED PANCREATIC ISLET ALLOGRAFTS IN RATS RENDERED IMMUNOLOGICALLY UNRESPONSIVE TO RENAL ALLOGRAFTSTransplantation, 1984